Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-12 · accession 0001193125-26-052055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-12 | JBIO | Balta Elizabeth | See Remarks | A - Grant | $0.00 | +28.1K | 28.1K | New | $0 |
| D | 2026-02-13 | 2026-02-12 | JBIO | Balta Elizabeth | See Remarks | A - Grant | $0.00 | +168.8K | 168.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | A | A | 28,125 | $0.00 | 28,125 | D | — | — | (F1) Represents restricted stock units ("RSUs"). 1/4 of the total number of RSUs granted shall vest on each of the first four anniversaries of February 15, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-12 | A | A | 168,750 | $0.00 | 168,750 | D | $14.81 · — to 2036-02-11 | 168,750 Common Stock | (F2) This option represents a right to purchase shares of the Issuer's common stock, one quarter of which will vest on February 15, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |